<DOC>
	<DOCNO>NCT01122108</DOCNO>
	<brief_summary>The objective study compare acceptability Colesevelam HCl powder oral suspension versus generic cholestyramine via BASA scale , base upon anticipated equivalent cholesterol lower dos comparator drug .</brief_summary>
	<brief_title>Comparison Colesevelam Hydrogen Chloride ( HCl ) Powder For Oral Suspension Versus Generic Cholestyramine Through Use Bile Acid Sequestrant Acceptability ( BASA ) Scale</brief_title>
	<detailed_description>In 2009 , colesevelam HCl approve powder formulation . Little objective evidence exists compare acceptability colesevelam HCl powder oral suspension formulation versus bile acid sequestrant powder formulation . A Bile Acid Sequestrant Acceptability ( BASA ) Scale develop validated instrument compare acceptability different bile acid sequestrant preparation</detailed_description>
	<mesh_term>Cholestyramine Resin</mesh_term>
	<mesh_term>Colesevelam Hydrochloride</mesh_term>
	<mesh_term>Bile Acids Salts</mesh_term>
	<criteria>Men woman 1870 year age In general good health ( define study participant medically stable , meet protocol criterion , may also nonexclusionary ongoing medical condition ) . Subjects capable give informed consent , appropriate , acceptable surrogate capable give consent subject 's behalf . Subjects willing readily able contact poststudy safety phone call assessments one seven day single study visit . Prior intolerance bile acid sequestrants Known Phenylketonuria . Colesevelam ( Welchol ) Oral Suspension contain 48 mg phenylalanine per 3.75 gram dose . Women either pregnant , practice form birth control . Prior gastrointestinal surgery History ongoing gastrointestinal symptom ( indigestion , constipation , diarrhea ) History bowel obstruction , malabsorption , irritable bowel syndrome History esophageal disease Current past history gallbladder disease History pancreatitis Subjects enrol another experimental ( interventional ) protocol within past 30 day prior visit 1 . Diagnosis diabetes mellitus Known history triglyceride level &gt; 300 mg/dl . History alcohol drug abuse within 1 year study entry Alcohol intake exceed 2 unit alcohol drink per day Exposure bile acid sequestrants ( colesevelam HCl , cholestyramine , colestipol within 30 day visit 1 ) . Any situation Investigator make judgment participation study would best interest study participant , best interest provide reliable study data .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Bile Acid Sequestrant</keyword>
	<keyword>Resin</keyword>
	<keyword>Lipids</keyword>
	<keyword>Glucose</keyword>
	<keyword>Cholesterol</keyword>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Bile Acid Sequestrant Acceptability Scale</keyword>
</DOC>